ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Cytek Biosciences Inc

Cytek Biosciences Inc (CTKB)

4,09
-0,24
(-5,54%)
Geschlossen 06 Juni 10:00PM
4,12
0,03
(0,73%)
Nach Börsenschluss: 1:54AM

Cytek Biosciences Inc (CTKB) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
4,12
( -4,85% )
Gebot
2,95
Fragen
4,97
Volumen
912.428
4,021 Tagesbereich 4,45
2,90 52-Wochen-Bereich 6,18
Marktkapitalisierung
Handelsende
4,33
Handelsbeginn
4,24
Letzte Trade
30
@
4.0697
Letzter Handelszeitpunkt
Finanzvolumen
US$ 3.794.347
VWAP
4,1585
Durchschnittliches Volumen (3 Mio.)
US$ 795.269
Ausgegebene Aktien
129.142.587
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-6,88
Gewinn pro Aktie (EPS)
-0,58
Erlöse (LTM)
204,17M
Nettogewinn (LTM)
-74M

Über Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora C... Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Fremont, United States
Gegründet
1992
Cytek Biosciences Inc is listed in the Healthcare sector of the NASDAQ with ticker CTKB. The last closing price for Cytek Biosciences was US$4,33. Over the last year, Cytek Biosciences shares have traded in a share price range of US$ 2,90 to US$ 6,18.

Cytek Biosciences currently has 129.142.587 shares in issue. The market capitalisation of Cytek Biosciences is US$532,07 million. Cytek Biosciences has a price to earnings ratio (PE ratio) of -6.88.

CTKB Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1004.124.394.028041474.19961427CS
4-0.37-8.240534521164.494.82893.3110922343.87271478CS
120.12344.993.317786424.22623784CS
26-1.065-20.54001928645.1856.043.318733874.58938179CS
520.7120.82111436953.416.182.910190634.31000082CS
156-3.88-48.589.872.378748145.42643367CS
260-15.98-79.502487562220.128.72.378204467.87955918CS

CTKB - Frequently Asked Questions (FAQ)

What is the current Cytek Biosciences Inc share price?
The current share price of Cytek Biosciences Inc is US$ 4,12
How many Cytek Biosciences Inc shares are in issue?
Cytek Biosciences Inc has 129.142.587 shares in issue
What is the market cap of Cytek Biosciences Inc?
The market capitalisation of Cytek Biosciences Inc is USD 532,07M
What is the 1 year trading range for Cytek Biosciences Inc share price?
Cytek Biosciences Inc has traded in the range of US$ 2,90 to US$ 6,18 during the past year
What is the PE ratio of Cytek Biosciences Inc?
The price to earnings ratio of Cytek Biosciences Inc is -6,88
What is the cash to sales ratio of Cytek Biosciences Inc?
The cash to sales ratio of Cytek Biosciences Inc is 2,52
What is the registered address of Cytek Biosciences Inc?
The registered address for Cytek Biosciences Inc is 47215 Lakeview Blvd, Fremont, California, 94538-6407
What is the Cytek Biosciences Inc website address?
The website address for Cytek Biosciences Inc is cytekbio.com
Which industry sector does Cytek Biosciences Inc operate in?
Cytek Biosciences Inc operates in the Biotechnology & Life Sciences sector

CTKB Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen